Update on Novel Agents in Prostate Cancer
Upon completion of this discussion, participants should be able to:
- Understand the role of disease heterogeneity in prostate cancer biology
- Identify emerging novel agents in clinical trials for prostate cancer
- Describe the impact of the rapidly changing landscape of precision medicine in prostate cancer
Recommended CitationHeath, MD, FACP, Elisabeth I., "Update on Novel Agents in Prostate Cancer" (2017). Kimmel Cancer Center, Presentations and Grand Rounds. Paper 46.